PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 47 |
| 2016 | 36 |
| 2017 | 32 |
| 2018 | 43 |
| 2019 | 56 |
| 2020 | 81 |
| 2021 | 173 |
| 2022 | 169 |
| 2023 | 85 |
| 2024 | 89 |
| 2025 | 124 |
| 2026 | 72 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"J Crohns Colitis"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Review: optimizing rescue therapy in acute severe ulcerative colitis using infliximab pharmacokinetics-a practical guide for clinicians.
- Con D, Li Wai Suen C, Choy M, Flegg JA, De Cruz P.
- J Crohns Colitis. 2026 Oct 9;20(10):jjag160. doi: 10.1093/ecco-jcc/jjag160.
- PMCID: PMC13694116
Con D, et al.J Crohns Colitis. 2026.PMCID: PMC13694116 -
Exploration of international differences in preoperative characteristics, indications, postoperative management and endoscopic recurrence rates in patients with Crohn's disease following ileocolic (re-)resection: first outcomes from the IMPACT consortium.
- Bak MTJ, Hammoudi N, Lee SH, Maggiori L, van Ruler O, Bezault M, Hernandez-Rocha C, de Vries AC, Silverberg MS, Allez M; IMPACT (International Multidisciplinary Research Collaboration on Postoperative IBD) consortium; on behalf of the Dutch Initiative on Crohn and Colitis and the RAP-CD study group; on behalf of the NIDDK Inflammatory Bowel Disease Genetics Consortium; on behalf of the REMIND study group.
- J Crohns Colitis. 2026 Oct 9;20(10):jjag137. doi: 10.1093/ecco-jcc/jjag137.
- PMCID: PMC13694115
Bak MTJ, et al.J Crohns Colitis. 2026.PMCID: PMC13694115 -
Perianal fistulizing Crohn's disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC).
- Mulders LGM, Anjie SI, Chevallot-Beroux M, Loeff F, Wildenberg ME, Mathôt RAA, D'Haens GRAM, Gecse KB.
- J Crohns Colitis. 2026 Oct 9;20(10):jjag151. doi: 10.1093/ecco-jcc/jjag151.
- PMCID: PMC13692796
Mulders LGM, et al.J Crohns Colitis. 2026.PMCID: PMC13692796 -
Trends in utilization of advanced therapies in patients with inflammatory bowel diseases in the USA, 2021-2025.
- Singh S, Desai A, Goodwin S, Jairath V, Kochhar G.
- J Crohns Colitis. 2025 Nov 8;19(10):jjaf186. doi: 10.1093/ecco-jcc/jjaf186.
- PMCID: PMC12616000
Singh S, et al.J Crohns Colitis. 2025.PMCID: PMC12616000 -
Building sustainable IBD clinical research units: a practical toolbox emerging from a Belgian multi-stakeholder initiative.
- Arijs I, Govaerts L, Debrun L, Fierens L, Franc K, Kelchtermans H, Minsart C, Reenaers C, Vandenbroucke L, Vansteenkiste L, De Rechter J; Belgian IBD Research and Development (BIRD); Verstockt B.
- J Crohns Colitis. 2026 Oct 9;20(10):jjag144. doi: 10.1093/ecco-jcc/jjag144.
- PMCID: PMC13682843
Arijs I, et al.J Crohns Colitis. 2026.PMCID: PMC13682843 -
Safety and tolerability of anti-toll-like receptor 3, monoclonal antibody PRV-300 in patients with moderate-to-severe ulcerative colitis: a randomized phase 1B clinical trial (PULSE).
- Pokryszka J, Comer GM, Richmond CA, Leon F, Reinisch W.
- J Crohns Colitis. 2026 Oct 9;20(10):jjag154. doi: 10.1093/ecco-jcc/jjag154.
- PMCID: PMC13680009
Pokryszka J, et al.J Crohns Colitis. 2026.PMCID: PMC13680009 -
Etrasimod reduces circulating and mucosal inflammatory lymphocyte populations and alters innate immune and non-immune cell signatures in intestinal mucosa: ELEVATE UC phase 3 clinical data.
- Siegmund B, Crosby CM, Ryan RD, Smith J, Abreu MT, Vermeire S, Dotan I, Rabinowitz KM, Komori HK, Goetsch M, Wosik K, Woolcott JC, Danese S.
- J Crohns Colitis. 2026 Oct 9;20(10):jjag159. doi: 10.1093/ecco-jcc/jjag159.
- PMCID: PMC13658268
Siegmund B, et al.J Crohns Colitis. 2026.PMCID: PMC13658268 -
Plasma lipopolysaccharide-binding protein (LBP), a proxy for intestinal permeability, relates to clinicopathological and immunological disease activity in inflammatory bowel disease patients at diagnosis and during disease course.
- Barendregt DMH, Tuk B, Hulleman-van Haaften DH, Camman AE, Calado B, Grillmaier MH, Smits WK, Doukas M, Escher JC, de Ridder L, Samsom JN.
- J Crohns Colitis. 2026 Oct 9;20(10):jjag146. doi: 10.1093/ecco-jcc/jjag146.
- PMCID: PMC13652030
Barendregt DMH, et al.J Crohns Colitis. 2026.PMCID: PMC13652030 -
Evaluating sonographic response and remission in inflammatory bowel disease: aligning intestinal ultrasound assessment with STRIDE-II timelines.
- Srinivasan AR, Sagami S, Nguyen A, Smith RL, Vasudevan A, Taylor SA.
- J Crohns Colitis. 2026 Sep 3;20(9):jjag132. doi: 10.1093/ecco-jcc/jjag132.
- PMCID: PMC13602416
Srinivasan AR, et al.J Crohns Colitis. 2026.PMCID: PMC13602416 -
Orofacial granulomatosis associated with Crohn's disease: clinical phenotype and response to biologics and Janus kinase inhibitor therapy in a large multi-center cohort.
- Lees RD, Patel P, Young G, Beck L, Marin AM, Parkinson D, Pele L, Parkes M, Sanderson J, Herbert C, Hullah E, Lamb CA, Mawdsley J, Speight RA.
- J Crohns Colitis. 2026 Sep 3;20(9):jjag139. doi: 10.1093/ecco-jcc/jjag139.
- PMCID: PMC13594358
Lees RD, et al.J Crohns Colitis. 2026.PMCID: PMC13594358